Indeloxazine acts as a [[serotonin releasing agent]], [[norepinephrine reuptake inhibitor]], and [[NMDA receptor antagonist]].<ref name="pmid9833647">{{cite journal |vauthors=Yamaguchi T, Ohyama M, Suzuki M | title = Neurochemical and behavioral characterization of potential antidepressant properties of indeloxazine hydrochloride | journal = Neuropharmacology | volume = 37 | issue = 9 | pages = 1169–76 | date= September 1998  | pmid = 9833647 | doi = 10.1016/s0028-3908(98)00009-4| url = http://linkinghub.elsevier.com/retrieve/pii/S0028390898000094|displayauthors=etal}}</ref><ref name="pmid1652446">{{cite journal |vauthors=Kaneko S, Sugimura M, Inoue T, Satoh M | title = Effects of several cerebroprotective drugs on NMDA channel function: evaluation using Xenopus oocytes and [3H]MK-801 binding | journal = European Journal of Pharmacology | volume = 207 | issue = 2 | pages = 119–28 | date = June 1991 | pmid = 1652446 | doi = 10.1016/0922-4106(91)90086-w| url = }}</ref> It has been found to enhance [[acetylcholine]] release in the rat [[forebrain]] through activation of the [[5-HT4 receptor|5-HT<sub>4</sub> receptor]] via its action as a serotonin releasing agent.<ref name="Peñas-CazorlaVilaró2014">{{cite journal|last1=Peñas-Cazorla|first1=Raúl|last2=Vilaró|first2=M. Teresa|title=Serotonin 5-HT4 receptors and forebrain cholinergic system: receptor expression in identified cell populations|journal=Brain Structure and Function|volume=220|issue=6|year=2014|pages=3413–3434|issn=1863-2653|doi=10.1007/s00429-014-0864-z}}</ref><ref name="pmid9453456">{{cite journal |vauthors=Yamaguchi T, Suzuki M, Yamamoto M | title = Facilitation of acetylcholine release in rat frontal cortex by indeloxazine hydrochloride: involvement of endogenous serotonin and 5-HT4 receptors | journal = Naunyn-Schmiedeberg's Archives of Pharmacology | volume = 356 | issue = 6 | pages = 712–20 | date = December 1997 | pmid = 9453456 | doi = 10.1007/pl00005110| url = http://link.springer.de/link/service/journals/00210/bibs/7356006/73560712.htm}}</ref><ref name="pmid8078992">{{cite journal |vauthors=Yamamoto M, Takahashi K, Ohyama M | title = Possible involvement of central cholinergic system in ameliorating effects of indeloxazine, a cerebral activator, on disturbance of learning behavior in rats | journal = Progress in Neuro-psychopharmacology & Biological Psychiatry | volume = 18 | issue = 3 | pages = 603–13 | date = May 1994 | pmid = 8078992 | doi = 10.1016/0278-5846(94)90016-7| url = |display-authors=etal}}</ref> The drug has been found to possess [[nootropic]],<ref name="pmid3219685">{{cite journal |vauthors=Ogawa N, Haba K, Sora YH, Higashida A, Sato H, Ogawa S | title = Comparison of the effects of bifemelane hydrochloride and indeloxazine hydrochloride on scopolamine hydrobromide-induced impairment in radial maze performance | journal = Clinical Therapeutics | volume = 10 | issue = 6 | pages = 704–11 | date = 1988 | pmid = 3219685 | doi = | url = }}</ref><ref name="pmid3627384">{{cite journal |vauthors=Yamamoto M, Shimizu M | title = Cerebral activating properties of indeloxazine hydrochloride | journal = Neuropharmacology | volume = 26 | issue = 7A | pages = 761–70 | date = July 1987 | pmid = 3627384 | doi = 10.1016/0028-3908(87)90239-5 }}</ref> [[neuroprotective]],<ref name="pmid3187197">{{cite journal | vauthors = Ogawa N, Haba K, Yoshikawa H, Ono T, Mizukawa K | title = Comparison of the effects of bifemelane hydrochloride, idebenone and indeloxazine hydrochloride on ischemia-induced depletion of brain acetylcholine levels in gerbils | journal = Res. Commun. Chem. Pathol. Pharmacol. | volume = 61 | issue = 2 | pages = 285–8 | date = 1988 | pmid = 3187197 | doi = | url = }}</ref><ref name="pmid3446040">{{cite journal |vauthors=Yamamoto M, Shimizu M, Sakamoto N, Ohtomo H, Kogure K | title = Protective effects of indeloxazine hydrochloride on cerebral ischemia in animals | journal = Archives Internationales de Pharmacodynamie et de Thérapie | volume = 290 | issue = 1 | pages = 16–24 | date =November  1987 | pmid = 3446040 | doi = | url = }}</ref><ref name="pmid8297184">{{cite journal |vauthors=Shimizu-Sasamata M, Terai M, Harada M, Yamamoto M | title = Anti-hypoxic and anti-ischemic actions of indeloxazine hydrochloride and its optical isomers: possible involvement of cerebral energy metabolism | journal = Archives Internationales de Pharmacodynamie et de Thérapie | volume = 324 | issue = | pages = 33–46 | date = 1993 | pmid = 8297184 | doi = | url = }}</ref><ref name="pmid3592867">{{cite journal |vauthors=Yamamoto M, Shimizu M | title = Effects of indeloxazine hydrochloride (YM-08054) on anoxia | journal = Archives Internationales de Pharmacodynamie et de Thérapie | volume = 286 | issue = 2 | pages = 272–81 | date = April 1987| pmid = 3592867 | doi = | url = }}</ref> [[anticonvulsant]],<ref name="pmid8327550">{{cite journal |vauthors=Nakamura J, Anraku T, Shirouzu M, Iwashita Y, Nakazawa Y | title = Effects of indeloxazine HCl on kindled amygdaloid seizures in rats: comparison with the effects of phenytoin, diazepam, ethanol, and imipramine | journal = Pharmacology, Biochemistry, and Behavior | volume = 45 | issue = 2 | pages = 445–50 | date = June 1993 | pmid = 8327550 | doi = 10.1016/0091-3057(93)90263-s| url = }}</ref> and [[antidepressant]]-like effects in [[animal model]]s.<ref name="pmid4092278" /><ref name="pmid9833647"/>
